Freeline Therapeutics Holdings Plc Debt to EBITDA Ratio 5 year CAGR is NA for the Trailing 12 Months (TTM) ending September 20, 2024. The debt to EBITDA ratio measures the amount of debt a company has relative to its earnings before interest, taxes, depreciation, and amortization (EBITDA). It is calculated by dividing total debt by EBITDA. This ratio helps assess a company's ability to service its debt obligations using its operating income. A higher ratio indicates a higher level of debt burden and potential financial risk. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.